Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 459852
                    [Title] => Statin reduces life-threatening leg vein clots
                    [Summary] => 
MANILA, Philippines - New findings from a landmark study revealed that the cholesterol-lowering drug rosuvastatin cuts the risk of venous thromboembolism (VTE) by 43 percent.
                    [DatePublished] => 2009-04-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 457561
                    [Title] => JUPITER study ushers in new paradigm
                    [Summary] => 
Local heart experts agree with their foreign colleagues that findings of a new landmark study will change the way doctors treat apparently healthy and low-risk patients.
                    [DatePublished] => 2009-04-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

INTERVENTION TRIAL EVALUATING ROSUVASTATIN

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 459852
                    [Title] => Statin reduces life-threatening leg vein clots
                    [Summary] => 
MANILA, Philippines - New findings from a landmark study revealed that the cholesterol-lowering drug rosuvastatin cuts the risk of venous thromboembolism (VTE) by 43 percent.
                    [DatePublished] => 2009-04-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 457561
                    [Title] => JUPITER study ushers in new paradigm
                    [Summary] => 
Local heart experts agree with their foreign colleagues that findings of a new landmark study will change the way doctors treat apparently healthy and low-risk patients.
                    [DatePublished] => 2009-04-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Statin reduces life-threatening leg vein clots

April 23, 2009 - 12:00am

MANILA, Philippines - New findings from a landmark study revealed that the cholesterol-lowering drug rosuvastatin cuts the risk of venous thromboembolism (VTE) by 43 percent.

Science and Environment

JUPITER study ushers in new paradigm

April 16, 2009 - 12:00am

Local heart experts agree with their foreign colleagues that findings of a new landmark study will change the way doctors treat apparently healthy and low-risk patients.

Science and Environment